本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Fate Therapeutics Inc

2.44
+0.09003.83%
盤後2.480.0400+1.64%19:48 EDT
成交量:127.70萬
成交額:308.29萬
市值:2.93億
市盈率:-2.32
高:2.47
開:2.35
低:2.35
收:2.35
52周最高:3.23
52周最低:0.9403
股本:1.20億
流通股本:1.05億
量比:1.81
換手率:1.22%
股息:- -
股息率:- -
每股收益(TTM):-1.0528
每股收益(LYR):-1.1500
淨資產收益率:-60.75%
總資產收益率:-26.22%
市淨率:1.91
市盈率(LYR):-2.12

資料載入中...

2024/02/26

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/02/26

重要事件披露

Form 8-K - Current report
2024/02/13

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/12

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/09

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/01/30

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/01/25

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/01/10

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/01/10

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/01/10

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/01/10

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/01/03

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/12/29

超過5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/12/19

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/11/22

SEC問詢函

Form CORRESP - Correspondence
2023/11/10

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/11/08

重要事件披露

Form 8-K - Current report
2023/11/08

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/08

重要事件披露

Form 8-K - Current report
2023/09/02

重要事件披露

Form 8-K - Current report